| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ASCO update—best of the best
|
Petzer, Andreas
|
|
|
15 |
4 |
p. 255-256
|
article
|
| 2 |
ASCO update: hepatocellular and cholangiocellular carcinoma
|
Djanani, Angela
|
|
|
15 |
4 |
p. 259-263
|
article
|
| 3 |
ASCO 2022 update: (neo-)adjuvant treatment of colorectal cancer
|
Piringer, Gudrun
|
|
|
15 |
4 |
p. 264-268
|
article
|
| 4 |
Best of ASCO 2022—bladder cancer
|
Pichler, Martin
|
|
|
15 |
4 |
p. 273-274
|
article
|
| 5 |
Best of ASCO 2022—central nervous system tumors
|
Leibetseder, Annette
|
|
|
15 |
4 |
p. 269-272
|
article
|
| 6 |
Bilateral primary breast lymphoma in a pregnant woman: a case report and literature review
|
Yildirim, Hasan Cagri
|
|
|
15 |
4 |
p. 307-310
|
article
|
| 7 |
Challenges in integrating molecular profiles into clinical cancer care
|
Jahn, Stephan W.
|
|
|
15 |
4 |
p. 303-306
|
article
|
| 8 |
Current standards in the surgical treatment of pancreatic and small intestinal neuroendocrine tumors
|
Klaiber, Ulla
|
|
|
15 |
4 |
p. 282-286
|
article
|
| 9 |
Endometrial cancer: news from ASCO
|
Petru, Edgar
|
|
|
15 |
4 |
p. 275-277
|
article
|
| 10 |
Essential news of current guidelines: head and neck squamous cell carcinoma
|
Fuereder, Thorsten
|
|
|
15 |
4 |
p. 278-281
|
article
|
| 11 |
From morphology to molecular targets—the pathologist’s view in diagnosing gastroenteropancreatic neuroendocrine neoplasms
|
Henzinger, Hanna
|
|
|
15 |
4 |
p. 287-293
|
article
|
| 12 |
Neuroendocrine neoplasms revisited—the challenges of reclassifying tumor
|
Kiesewetter, Barbara
|
|
|
15 |
4 |
p. 257-258
|
article
|
| 13 |
Pharmacokinetic drug interactions of oral anticancer drugs
|
Gampenrieder Satory, Julia
|
|
|
15 |
4 |
p. 298-302
|
article
|
| 14 |
The NET G3 enigma: dealing with a “new” entity
|
Raderer, Markus
|
|
|
15 |
4 |
p. 294-297
|
article
|
Journal description